about
Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [ISRCTN38432711].Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]Hass avocado composition and potential health effectsDecrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritisChondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibitionDoes protein kinase R mediate TNF-alpha- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism?The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta.Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro studyPROSPECTIVE EFFECT OF RED ALGAE, ACTINOTRICHIA FRAGILIS, AGAINST SOME OSTEOARTHRITIS AETIOLOGY.Integrin α1β1 differentially regulates cytokine-mediated responses in chondrocytes.High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes.Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro.Current nutraceuticals in the management of osteoarthritis: a reviewEdible Bird's nest extract as a chondro-protective agent for human chondrocytes isolated from osteoarthritic knee: in vitro study.The role of platelet gel in osteoarticular injuries of young and old patients.Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.sb203580 preconditioning recharges matrix-expanded human adult stem cells for chondrogenesis in an inflammatory environment - A feasible approach for autologous stem cell based osteoarthritic cartilage repair.Bovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synoviumA potential role for avocado- and soybean-based nutritional supplements in the management of osteoarthritis: a review.What about supplements for osteoarthritis? A critical and evidenced-based review.Cinnamophilin isolated from Cinnamomum philippinense protects against collagen degradation in human chondrocytes.Regulation of hypoxia-inducible factor-1α (HIF-1α) expression by interleukin-1β (IL-1 β), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes.IL37 dampens the IL1β-induced catabolic status of human OA chondrocytes.Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint.TGF-beta inhibits IL-1beta-activated PAR-2 expression through multiple pathways in human primary synovial cells.In vitro suppression of the MMP-3 gene in normal and cytokine-treated human chondrosarcoma using small interfering RNA.Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factorAnti-inflammatory effects of Cynanchum taiwanianum rhizome aqueous extract in IL-1β-induced NRK-52E cells.Vacuolar Protein Sorting 4B (VPS4B) Regulates Apoptosis of Chondrocytes via p38 Mitogen-Activated Protein Kinases (MAPK) in Osteoarthritis.Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis.
P2860
Q21245659-027CCC83-0EA4-4A36-B415-B75071BACED9Q21254655-E66225F8-51D9-425F-8950-C90E88699B7EQ24619209-6D01260E-A04E-4BD4-B312-7ADF5828F78DQ24684384-CFC87485-4952-49AA-9DDD-000FFE4E58C0Q24793013-1C95FD5D-91E0-4CDF-B86C-73AAB7197A55Q24793070-230D6DBF-1993-4836-AC30-AF0F3415A38EQ33239303-E8E92C0C-D57E-4179-9029-6830C6C2B309Q33243271-D714E21B-5241-4560-82FB-7FC36AAA140AQ33623004-AD9DF158-08DD-41CD-8DD3-36720ED8F5EFQ33638043-0547ABEF-A0F2-454B-9E08-0A2F66870500Q34153150-509016B3-BFEA-45B4-9050-EC4077B098CCQ34226676-8372185B-DA3C-4335-80B8-C2C7D0DF686AQ34291608-AF66525B-69B4-4A90-9E30-482B625BE946Q34557007-5AA42D11-975F-4CEC-BC1B-59B60BDEB87FQ34678133-1828CE15-6222-4043-89AE-D62062F83617Q35135845-4080FDF7-3305-483F-AC6C-C172190E3157Q35617712-A7138421-4349-4510-AC32-9B1EEB8CE108Q35854886-4C984419-3329-4A1F-91F3-CFB68CE99033Q36295868-DDAA1E96-9E25-4AFB-B3F3-821F12572C92Q37772730-7332A002-F412-4B7D-959B-C0B65EE426F5Q37868775-60C0C48D-D999-4269-B8D7-0CCDF62719B4Q39295136-017D9C99-E652-4C5A-990C-1627DBAF7A91Q40065349-41794ECD-D098-453E-AA91-DDC4CBBA3C24Q40430530-45385B27-8FD3-4BC1-AC36-876EC68300D5Q41011694-F5C69B51-6B17-4FEF-8383-05EF0C291A66Q41856140-5CB917DD-0B57-43A6-A929-6F7787FB0B11Q41900874-385AC5E1-B526-4F77-AA16-5E08C600CCFFQ44124056-66CDBA3B-3708-4DCD-A201-B964D6FFA71EQ47315422-7B30A817-C231-488B-A3DA-510BE81E849AQ48027015-C60A1AD7-756C-471B-BC9D-4BDBE555E41EQ51576370-872501CA-9C21-4A7D-8F82-010D090D4B71Q52974832-6621A5F5-D20A-4FB2-BDE7-F9908C80F6A2
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Anabolic and destructive mediators in osteoarthritis.
@ast
Anabolic and destructive mediators in osteoarthritis.
@en
type
label
Anabolic and destructive mediators in osteoarthritis.
@ast
Anabolic and destructive mediators in osteoarthritis.
@en
prefLabel
Anabolic and destructive mediators in osteoarthritis.
@ast
Anabolic and destructive mediators in osteoarthritis.
@en
P1476
Anabolic and destructive mediators in osteoarthritis.
@en
P2093
van den Berg WB
van der Kraan PM
P304
P356
10.1097/00075197-200005000-00007
P577
2000-05-01T00:00:00Z